CIAM
PACB icon

Caitong International Asset Management’s Pacific Biosciences PACB Stock Holding History

Caitong International Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.4K Buy
41,895
+38,537
+1,148% +$56K 0.01% 638
2026
Q1 		$4.43K Sell
3,358
-7,013
-68% -$12.5K ﹤0.01% 1155
2025
Q4 		$19.4K Sell
10,371
-12,405
-54% -$23.8K ﹤0.01% 995
2025
Q3 		$29.2K Buy
22,776
+20,478
+891% +$27.7K 0.02% 508
2025
Q2 		$2.85K Sell
2,298
-14,401
-86% -$16.6K ﹤0.01% 1254
2025
Q1 		$19.7K Buy
+16,699
New +$25.6K 0.01% 744

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Caitong International Asset Management's PACB Position: Q2 2026 in Review

Caitong International Asset Management increased its Pacific Biosciences (PACB) stake by 1,148% in Q2 2026, buying an estimated $56K and bringing the position to 41,895 shares worth $70.4K. The position accounts for 0.01% of the portfolio, ranked #638.

Caitong International Asset Management first reported a position in PACB in Q1 2025 and has held it in 6 quarters since. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Caitong International Asset Management held 41,895 shares of Pacific Biosciences worth $70.4K as of Q2 2026.
  • Caitong International Asset Management bought 38,537 Pacific Biosciences shares in Q2 2026, an estimated $56K.
  • Pacific Biosciences made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #638 holding.
  • Caitong International Asset Management first reported a position in Pacific Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.